Five Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib (APC) Trial

The Adenoma Prevention with Celecoxib (APC) Trial examined the efficacy and safety of the Cox-2 inhibitor, celecoxib, for sporadic colorectal adenoma prevention in patients at high risk for colorectal cancer (CRC). The trial randomized 2035 subjects to receive either placebo, celecoxib 200mg twice d...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Bertagnolli, Monica M., Eagle, Craig J., Zauber, Ann G., Redston, Mark, Breazna, Aurora, Kim, KyungMann, Tang, Jie, Rosenstein, Rebecca B., Umar, Asad, Bagheri, Donya, Collins, Neal T., Burn, John, Chung, Daniel C., Dewar, Thomas, Foley, T. Raymond, Hoffman, Neville, Macrae, Finlay, Pruitt, Ronald E., Saltzman, John R., Salzberg, Bruce, Sylwestrowicz, Thomas, Hawk, Ernest T.
Формат: Artigo
Язык:Inglês
Опубликовано: 2009
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2976587/
https://ncbi.nlm.nih.gov/pubmed/19336730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-08-0206
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы